Author

Sara D. Allstadt

Observed names: S. D. Allstadt, S.D. Allstadt, Sara Allstadt

Observed institutions: University of Tennessee System, University of Tennessee at Knoxville, University of California, Davis

ORCID: 0000-0002-9051-523X

Observed ORCID: 0000-0002-9051-523X

OpenAlex ID: A5041828023

Treatment of feline intermediate‐ to high‐grade lymphoma with a modified university of Wisconsin–Madison protocol: 119 cases (2004–2012)

2015 · S. A. Collette, S. D. Allstadt, et al. · Veterinary and Comparative Oncology · 89

Randomized Phase III Trial of Piroxicam in Combination with Mitoxantrone or Carboplatin for First-Line Treatment of Urogenital Tract Transitional Cell Carcinoma in Dogs

2015 · S.D. Allstadt, C.O. Rodriguez, et al. · Journal of Veterinary Internal Medicine · 70

Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2017 · Shruthi Naik, Gina D. Galyon, et al. · Molecular Cancer Therapeutics · 64

Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs

2021 · Amy K. LeBlanc, Christina N. Mazcko, et al. · Clinical Cancer Research · 55

Treatment outcomes and prognostic factors of feline splenic mast cell tumors: A multi‐institutional retrospective study of 64 cases

2017 · B. J. Evans, D. O'Brien, et al. · Veterinary and Comparative Oncology · 30

A Comparative Oncology Study of Iniparib Defines Its Pharmacokinetic Profile and Biological Activity in a Naturally-Occurring Canine Cancer Model

2016 · Corey Saba, Melissa Paoloni, et al. · PLoS ONE · 27

Lower Urinary Tract Cancer

2015 · Claire M. Cannon, Sara D. Allstadt · Veterinary Clinics of North America Small Animal Practice · 27

Association between environmental factors including second‐hand smoke and primary lung cancer in dogs

2017 · A. Zierenberg‐Ripoll, R. E. Pollard, et al. · Journal of Small Animal Practice · 25

Pharmacokinetics of orally administered low-dose rapamycin in healthy dogs

2015 · Jeanne C. Larson, Sara D. Allstadt, et al. · American Journal of Veterinary Research · 21

Early findings from a comparative oncology study evaluating systemic VSV therapy in client-owned dogs with spontaneous hematologic malignancies

2014 · Shruthi Naik, Alyssa Leblanc, et al. · Human Gene Therapy · 1

Phase I study of rosiglitazone in combination with carboplatin in cancer bearing dogs

2011 · Sara D. Allstadt · 1

A Simple and Extractionless High-Performance Liquid Chromatography-Tandem-Mass Spectrometry (HPLC-MS/MS) Method for the Detection and Quantitation of Rosiglitazone in Canine Plasma

2010 · Sara D. Allstadt · 1

One Health in Oncology: Are integrated Human-Veterinary Centers the Next Frontier in Clinical Research?

2026 · Isabelle Vanhaezebrouck, Sara Allstadt, et al. · SSRN Electronic Journal

Supplemental Figure 2 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Figure 1 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Table 2 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplementary Table 1 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Figure 3 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplementary Figure Legends from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplementary Figure Legends from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Table 2 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplementary Table 1 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Figure 1 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Figure 2 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Supplemental Figure 3 from Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer

2023 · Shruthi Naik, Gina D. Galyon, et al.

Works count: 58

Citation count: 411

H-index: 9

I10-index: 9